Nexus provides contract research and laboratory services for public sector researchers and commercial health innovators. We support IRB-backed clinical trials, prevalence studies, and federal surveillance programs.
For diagnostic developers, we provide laboratory testing, analytical validation, and performance evaluation services for assays using a variety of specimen types, including self-collected specimens such as swabs and dried blood spots, where appropriate. We work with clients throughout the assay development and validation process, generating the laboratory data that supports their development programs.
One CLIA-certified, CAP-accredited laboratory, built for high-throughput work.
Nexus is a clinical diagnostics partner to digital health, home health, and virtual care brands that depend on operational speed and clean data workflows.
Leverage Nexus as your lab partner across Phase I–IV trials, pilot studies, or post-market research, especially when studies involve self-collection or decentralized protocols.
Run epidemiological or surveillance studies with high-throughput capacity, CLIA/CAP credentials, and the ability to support multi-state operations and regulatory alignment.
Integrate structured results from validated tests without delays, manual workarounds, or uncertainty. Nexus makes diagnostic operations reliable behind the scenes.
Partner with us to validate novel assays, evaluate self-collected specimen types, and provide laboratory testing and validation services to support the development of home-use and point-of-care diagnostic programs.
Partner with a laboratory that supports fast-moving development teams through laboratory testing, assay validation, workflow integration, and scalable laboratory operations.
Collaborate on new test development - from benchtop prototype to validated, lab-ready workflow.
Use Nexus for IRB-approved protocols, Phase I–IV trials, and post-market surveillance programs.
Run large-scale surveillance or prevalence studies with high-throughput capacity and structured data output.
What contract research services does Nexus provide?
Supports contract research services, including development and validation of laboratorydeveloped tests (LDTs) performed and used within the Company’s CLIA-certified laboratory, as well as clinical trial testing and public health studies.
Is Nexus experienced with regulatory protocols?
Yes, Nexus has supported IRB-approved trials, public agency studies, and enterprise procurement processes including FDA-aligned assay validation.
How long does validation take?
For a single analyte, single collection device, and single sample type: typically, 8 to 12 weeks from first experiment to final report. Timeline increases for more complex programs. Tell us what you’re working with, and we’ll give you a realistic estimate.
What sample types do you work with?
From standard clinical matrices to self-collected specimens, and even entirely novel sample types, we’re equipped to support a wide range of inputs. If your matrix is unconventional or hasn’t been widely validated before, that’s exactly the kind of challenge we’re built to take on.
Can Nexus support the transition of lab tests to use at-home or self-collected samples?
Nexus has extensive experience supporting the evaluation, analytical validation, and clinical performance of laboratory tests using self-collected specimen types, including dried blood spot (DBS) samples, as an alternative to traditionally clinician-collected specimens such as venous blood. These services are performed within Nexus’ CLIA-certified laboratory to support assay development, validation, and performance evaluation
Whether you’re launching a decentralized trial or designing your next diagnostic product, Nexus brings the speed, compliance, and execution to get there. Let’s talk through your workflow, protocol, and technical goals.